Sopran - Omeprazole Treatment Versus Surgery
Omeprazole Versus Anti-reflux Surgery in the Long-term Management of Peptic Esophagitis - a 10 Year Follow up Study of Patients Previously Studied for 5 Years - A Nordic Multicentre Study
2 other identifiers
interventional
219
4 countries
13
Brief Summary
The purpose of this study is to study gastritis, GI symptoms during long term omeprazole treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 1998
Longer than P75 for phase_3
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1998
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
November 20, 2005
CompletedFirst Posted
Study publicly available on registry
November 22, 2005
CompletedJanuary 24, 2011
January 1, 2011
7.8 years
November 20, 2005
January 21, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine the safety of omeprazole during long term treatment
Secondary Outcomes (1)
To investigate the long term control of reflux symptoms, healing of esophagitis and persistence of post fundoplication symptoms during long term treatment of omeprazole
Interventions
Eligibility Criteria
You may not qualify if:
- Pregnancy or lactation; Woman planning pregnancy within 5 years; Suspected or confirmed malignancy; Documented eradication of Helicobacter pylori.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (13)
Research Site
Aalborg, Denmark
Research Site
Glostrup Municipality, Denmark
Research Site
Hillerød, Denmark
Research Site
Kolding, Denmark
Research Site
Odense, Denmark
Research Site
Roskilde, Denmark
Research Site
Kuopio, Finland
Research Site
Bergen, Norway
Research Site
Oslo, Norway
Research Site
Trondheim, Norway
Research Site
Gothenburg, Sweden
Research Site
Örebro, Sweden
Research Site
Stockholm, Sweden
Related Publications (1)
Attwood SE, Ell C, Galmiche JP, Fiocca R, Hatlebakk JG, Hasselgren B, Langstrom G, Jahreskog M, Eklund S, Lind T, Lundell L. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther. 2015 Jun;41(11):1162-74. doi: 10.1111/apt.13194. Epub 2015 Apr 10.
PMID: 25858519DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
AstraZeneca GI Medical Science Director, MD
AstraZeneca
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 20, 2005
First Posted
November 22, 2005
Study Start
January 1, 1998
Primary Completion
October 1, 2005
Study Completion
October 1, 2005
Last Updated
January 24, 2011
Record last verified: 2011-01